Arunjyoti Bio Ventures News

Arunjyoti Bio Ventures Reports Q4FY26 Audited Results

Arunjyoti Bio Ventures posted a net loss of ₹453.61 lakhs for FY26, with Q4FY26 revenue from operations at ₹723.73 lakhs. Exceptional items of ₹273.65 lakhs impacted quarterly results.

Arunjyoti Bio Ventures Postpones Board Meeting

Arunjyoti Bio Ventures Limited has postponed its Board Meeting from 12.05.2026 to 13.05.2026. The agenda for the meeting remains unchanged.

Arunjyoti Bio Ventures Board Meet Rescheduled to May 12

Arunjyoti Bio Ventures Limited has postponed its board meeting from May 8, 2026, to May 12, 2026, due to unavoidable reasons. The agenda remains unchanged.

Arunjyoti Bio Ventures Board Meet on May 8, 2026

Arunjyoti Bio Ventures Limited announces board meeting scheduled for May 8, 2026, to consider audited financial results for Q4 and year ended March 31, 2026.

Arunjyoti Bio Ventures: Chennupati Sarath Kumar Acquires Shares

Chennupati Sarath Kumar acquired 54,25,516 equity shares of Arunjyoti Bio Ventures Limited through open market transactions, increasing his shareholding from 7.57% to 4.66% as disclosed under SEBI regulations.